Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma.

Sarcoma · 2016 · PMC5118533 · PMID 27895527

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Significant changes were not observed in concentrations of VEGF or PlGF peptides although there was a nonsignificant trend to decreasing concentrations of both of these peptides on day 22.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.